Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts
- PMID: 20542841
- DOI: 10.1684/ejd.2010.0932
Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts
Abstract
Acute generalized exanthematous pustulosis (AGEP) is a significant adverse cutaneous reaction, most often provoked by drugs and acute infections. The recognition of AGEP is important, in order to avoid confusion with a systemic infection and consequently to avoid incorrect treatment. The clinical hallmark is the presence of multiple disseminated sterile pustules on an erythematous background, associated with fever and a massive neutrophilia and sometimes eosinophilia. The disease is characterised by an acute onset and a spontaneous resolution within 2 weeks. The involvement of drug-specific T cells in the pathomechanism can be confirmed by positive skin patch tests and lymphocyte transformation tests. In this review, we highlight the main clinical, pathophysiological and diagnostic aspects of this peculiar form of drug allergy.
Similar articles
-
Acute generalized exanthematous pustulosis (AGEP): A review and update.J Am Acad Dermatol. 2015 Nov;73(5):843-8. doi: 10.1016/j.jaad.2015.07.017. Epub 2015 Sep 6. J Am Acad Dermatol. 2015. PMID: 26354880 Review.
-
T-cell involvement in drug-induced acute generalized exanthematous pustulosis.J Clin Invest. 2001 Jun;107(11):1433-41. doi: 10.1172/JCI12118. J Clin Invest. 2001. PMID: 11390425 Free PMC article.
-
Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.Int J Dermatol. 2010 May;49(5):507-12. doi: 10.1111/j.1365-4632.2010.04313.x. Int J Dermatol. 2010. PMID: 20534083
-
Acute generalized exanthematous pustulosis induced by itraconazole: an immunological approach.Clin Exp Dermatol. 2009 Dec;34(8):e709-11. doi: 10.1111/j.1365-2230.2009.03440.x. Epub 2009 Jul 3. Clin Exp Dermatol. 2009. PMID: 20055840
-
Acute generalised exanthematous pustulosis.Australas J Dermatol. 2012 May;53(2):87-92. doi: 10.1111/j.1440-0960.2011.00845.x. Epub 2011 Dec 29. Australas J Dermatol. 2012. PMID: 22571555 Review.
Cited by
-
Severe Cutaneous Adverse Reactions: A Single-Center Retrospective Study of 173 Patients in China.Ann Dermatol. 2019 Oct;31(5):545-554. doi: 10.5021/ad.2019.31.5.545. Epub 2019 Aug 30. Ann Dermatol. 2019. PMID: 33911647 Free PMC article.
-
Tosufloxacin-induced acute generalized exanthematous pustulosis confirmed by a drug-induced lymphocyte stimulation test.JAAD Case Rep. 2020 Aug 3;6(10):1016-1018. doi: 10.1016/j.jdcr.2020.07.049. eCollection 2020 Oct. JAAD Case Rep. 2020. PMID: 32995434 Free PMC article. No abstract available.
-
Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed?J Clin Med. 2022 Dec 8;11(24):7291. doi: 10.3390/jcm11247291. J Clin Med. 2022. PMID: 36555908 Free PMC article. Review.
-
Baboon syndrome: an unusual complication arising from antibiotic treatment of tonsillitis and review of the literature.BMJ Case Rep. 2013 Nov 28;2013:bcr2013201977. doi: 10.1136/bcr-2013-201977. BMJ Case Rep. 2013. PMID: 24287484 Free PMC article. Review.
-
Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):21-33. doi: 10.1016/j.jaip.2013.11.005. J Allergy Clin Immunol Pract. 2014. PMID: 24565765 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources